Revisiting beta-casein as a stabilizer for lipid liquid crystalline nanostructured particles

Jiali Zhai, Lynne Waddington, Timothy J Wooster, Marie-Isabel Aguilar, Benjamin J Boyd

Research output: Contribution to journalArticleResearchpeer-review

56 Citations (Scopus)


Lipid liquid crystalline nanoparticles such as cubosomes and hexosomes have unique internal nanostructures that have shown great potential in drug and nutrient delivery applications. The triblock copolymer, Pluronic F127, is usually employed as a steric stabilizer in dispersions of lipid nanostructured particles. In this study, we investigated the formation, colloidal stability and internal nanostructure and morphology of glyceryl monooleate (GMO) and phytantriol (PHYT) cubosome dispersions on substituting beta-casein with F127 in increasing proportion as the stabilizer. Internal structure and particle morphology were evaluated using small angle X-ray scattering (SAXS) and cryo-transmission electron microscopy (cryo-TEM), while protein secondary structure was studied using synchrotron radiation circular dichroism (SRCD). The GMO cubosome dispersion stabilized by beta-casein alone displayed a V2 (Pn3m) phase structure and a V2 to H2 phase transition at 60 degrees C. In comparison, F127-stabilized GMO dispersion had a V2 (Im3m) phase structure and the H2 phase only appeared at higher temperature, i.e. 70 degrees C. In the case of PHYT dispersions, only the V2 (Pn3m) phase structure was observed irrespective of the type and concentration of stabilizers. However, beta-casein-stabilized PHYT dispersion displayed a V2 to H2 to L2 transition behaviour upon heating, whereas F127-stabilized PHYT dispersion displayed only a direct V2 to L2 transition. The protein secondary structure was not disturbed by interaction with GMO or PHYT cubosomes. The results demonstrate that beta-casein provides steric stabilization to dispersions of lipid nanostructured particles and avoids the transition to Im3m structure in GMO cubosomes, but also favours the formation of the H2 phase, which has implications in drug formulation and delivery applications.
Original languageEnglish
Pages (from-to)14757 - 14766
Number of pages10
Issue number24
Publication statusPublished - 2011

Cite this